Knocking out IL-6 by vaccination

European Journal of Immunology

Volumn 34, Issue 1, 2004, Pages 291-300

  Gelle, Pia ^a   Hougs, Lotte ^a   Barington, Torben ^b   Svenson, Morten ^a   Svejgaard, Arne ^a   Thomsen, Allan R ^c   Bendtzen, Klaus ^a   Hansen, Morten Bagge ^a,d  

^a Rigshospitalet   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d Mental Health Services CPH   (Denmark)

Author keywords

Autoimmunity; Inflammation; Interleukin 6; Tolerance; Vaccination

Indexed keywords

AMINO ACID; ANTIBODY; DRUG DERIVATIVE; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; INTERLEUKIN 6 RECEPTOR; NEUTRALIZING ANTIBODY; SERUM AMYLOID A; TURPENTINE; VACCINE;

ACUTE PHASE RESPONSE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; EXPERIMENTAL MODEL; FEMALE; GENE MUTATION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INFLAMMATION; INHIBITION KINETICS; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR GENETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TERTIARY STRUCTURE; RECEPTOR BLOCKING; VACCINATION; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; FEMALE; HUMANS; INTERLEUKIN-6; MICE; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; VACCINES;

EID: 1642554771     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324338     Document Type: Article

References (45)

1. Van Snick, J., Interleukin-6: an overview. Annu. Rev. Immunol. 1990. 8: 253-278.
2. Akira, S., Taga, T. and Kishimoto, T., Interleukin-6 in biology and medicine. Adv. Immunol. 1993. 54: 1-78.
3. Xia, X., Lee, H. K., Clark, S. C. and Choi, Y. S., Recombinant interleukin (IL) 2-induced human B cell differentiation is mediated by autocrine IL-6. Eur. J. Immunol. 1989. 19: 2275-2281.
4. Garman, R. D., Jacobs, K. A., Clark, S. C. and Raulet, D. H., B-cell-stimulatory factor 2 (beta 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells. Proc. Natl. Acad. Sci. USA 1987. 84: 7629-7633.
5. Takai, Y., Wong, G. G., Clark, S. C., Burakoff, S. J. and Herrmann, S. H., B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. J. Immunol. 1988. 140: 508-512.
6. Baumann, H., Jahreis, G. P., Sauder, D. N. and Koj, A., Human keratinocytes and monocytes release factors which regulate the synthesis of major acute phase plasma proteins in hepatic cells from man, rat, and mouse. J. Biol. Chem. 1984. 259: 7331-7342.
7. Gauldie, J., Richards, C., Harnish, D., Lansdorp, P. and Baumann, H., Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc. Natl. Acad. Sci. USA 1987. 84: 7251-7255.
8. Ikebuchi, K., Wong, G. G., Clark, S. C., Ihle, J. N., Hirai, Y. and Ogawa, M., Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc. Natl. Acad. Sci. USA 1987. 84: 9035-9039.
9. Han, Z. C., Bellucci, S. and Caen, J. P., Megakaryocytopoiesis: characterization and regulation in normal and pathologic states. Int. J. Hematol. 1991. 54: 3-14.
10. Suematsu, S., Matsusaka, T., Matsuda, T., Ohno, S., Miyazaki, J., Yamamura, K., Hirano, T. and Kishimoto, T., Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice. Proc. Natl. Acad. Sci. USA 1992. 89: 232-235.
11. Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O. and Tanaka, H., Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 1988. 332: 83-85.
12. Woodroofe, C., Muller, W. and Ruther, U., Long-term consequences of interleukin-6 overexpression in transgenic mice. DNA Cell. Biol. 1992. 11: 587-592.
13. Girasole, G., Jilka, R. L., Passeri, G., Boswell, S., Boder, G., Williams, D. C. and Manolagas, S. C., 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J. Clin. Invest. 1992. 89: 883-891.
14. Campbell, I. L., Kay, T. W., Oxbrow, L. and Harrison, L. C., Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J. Clin. Invest. 1991. 87: 739-742.
15. Alonzi, T., Fattori, E., Lazzaro, D., Costa, P., Probert, L., Kollias, G., De-Benedetti, F., Poli, V. and Ciliberto, G., Interleukin 6 is required for the development of collagen-induced arthritis. J. Exp. Med. 1998. 187: 461-468.
16. Campbell, I. K., Hamilton, J. A. and Wicks, I. P., Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis. Eur J. Immunol. 2000. 30: 1568-1575.
17. Eugster, H. P., Frei, K., Kopf, M., Lassmann, H. and Fontana, A., IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 1998. 28: 2178-2187.
18. Stein, B. and Sutherland, M. K., IL-6 as a drug discovery target. Drug Discov. Today 1998. 3: 202-213.
19. Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H. and Kohler, G., Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994. 368: 339-342.
20. Klein, B. and Brailly, H., Cytokine-binding proteins: stimulating antagonists. Immunol. Today 1995. 16: 216-220.
21. Mihara, M., Nishimoto, N., Yoshizaki, K. and Suzuki, T., Influences of anti-mouse interleukin-6 receptor antibody on immune responses in mice. Immunol. Lett. 2002. 84: 223-229.
22. Ciapponi, L., Maione, D., Scoumanne, A., Costa, P., Hansen, M. B., Svenson, M., Bendtzen, K., Alonzi, T., Paonessa, G., Cortese, R., Ciliberto, G. and Savino, R., Induction of interleukin-6 (IL-6) autoantibodies through vaccination with an engineered IL-6 receptor antagonist. Nat. Biotechnol. 1997. 15: 997-1001.
23. Ward, L. D., Hammacher, A., Zhang, J. G., Weinstock, J., Yasukawa, K., Morton, C. J., Norton, R. S. and Simpson, R. J., Role of the C-terminus in the activity, conformation, and stability of interleukin-6. Protein Sci. 1993. 2: 1472-1481.
24. Hammacher, A., Ward, L. D., Weinstock, J., Treutlein, H., Yasukawa, K. and Simpson, R. J., Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding. Protein Sci. 1994. 3: 2280-2293.
25. Somers, W., Stahl, M. and Seehra, J. S., 1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling. EMBO J. 1997. 16: 989-997.
26. Paonessa, G., Graziani, R., De Serio, A., Savino, R., Ciapponi, L., Lahm, A., Salvati, A. L., Toniatti, C. and Ciliberto, G. Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling. EMBO J. 1995. 14: 1942-1951.
27. Simpson, R. J., Moritz, R. L., Rubira, M. R. and Van-Snick, J., Murine hybridoma/plasmacytoma growth factor. Complete amino-acid sequence and relation to human interleukin-6. Eur. J. Biochem. 1988. 176: 187-197.
28. Simpson, R. J., Moritz, R. L., Van, R. and Van Snick, J., Characterization of a recombinant murine interleukin-6: assignment of disulfide bonds. Biochem. Biophys. Res. Commun. 1988. 157: 364-372.
29. Taga, T. and Kishimoto, T., Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 1997. 15: 797-819.
30. Brakenhoff, J. P., de-Hon, F. D., Fontaine, V., ten-Boekel, E., Schooltink, H., Rose, J. S., Heinrich, P. C., Content, J. and Aarden, L. A., Development of a human interleukin-6 receptor antagonist. J. Biol. Chem. 1994. 269: 86-93.
31. De Benedetti, F., Pignatti, P., Vivarelli, M., Meazza, C., Ciliberto, G., Savino, R. and Martini, A., In vivo neutralization of human IL-6 (hIL-6) achieved by immunization of hIL-6-transgenic mice with a hIL-6 receptor antagonist. J. Immunol. 2001. 166: 4334-4340.
32. Zagury, D., Burny, A. and Gallo, R. C., Toward a new generation of vaccines: the anti-cytokine therapeutic vaccines. Proc. Natl. Acad. Sci. USA 2001. 98: 8024-8029.
33. Hansen, M. B., Svenson, M., Diamant, M., Abell, K. and Bendtzen, K., Interleukin-6 autoantibodies: possible biological and clinical significance. Leukemia 1995. 9: 1113-1115.
34. Fattori, E., Cappelletti, M., Costa, P., Sellitto, C., Cantoni, L., Carelli, M., Faggioni, R., Fantuzzi, G., Ghezzi, P. and Poli, V., Defective inflammatory response in interleukin 6-deficient mice. J. Exp. Med. 1994. 180: 1243-1250.
35. Hansen, M. B., Svenson, M., Diamant, M., Ross, C. and Bendtzen, K., Interleukin-6 (IL-6) autoantibodies and blood IL-6 measurements. Blood 1995. 85: 1145.
36. Ross, C., Svenson, M., Nielsen, H., Lundsgaard, C., Hansen, M. B. and Bendtzen, K, Increased in vivo antibody activity against interferon alpha, interleukin-1alpha, and interleukin-6 after high-dose Ig therapy. Blood 1997. 90: 2376-2380.
37. Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van, H., V, Sozzani, S., Bussolino, F., Poli, V., Ciliberto, G. and Mantovani, A., Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997. 6: 315-325.
38. Hurst, S. M., Wilkinson, T. S., McLoughlin, R. M., Jones, S., Horiuchi, S., Yamamoto, N., Rose-John, S., Fuller, G. M., Topley, N. and Jones, S. A., IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 2001. 14: 705-714.
39. Marin, V., Montero-Julian, F. A., Gres, S., Boulay, V., Bongrand, P., Farnarier, C. and Kaplanski, G., The IL-6-soluble IL-6R alpha autocrine loop of endothelial activation as an intermediate between acute and chronic inflammation: an experimental model involving thrombin. J. Immunol. 2001. 167: 3435-3442.
40. Kaplanski, G., Marin, V., Montero-Julian, F. A., Mantovani, A. and Farnarier, C., IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol. 2003. 24: 25-29.
41. Homann, C., Hansen, M. B., Graudal, N., Hasselqvist, P., Svenson, M., Bendtzen, K., Thomsen, A. C. and Garred, P., Anti-interleukin-6 autoantibodies in plasma are associated with an increased frequency of infections and increased mortality of patients with alcoholic cirrhosis. Scand. J. Immunol. 1996. 44: 623-629.
42. Hougs, L., Juul, L., Ditzel, H. J., Heilmann, C., Svejgaard, A. and Barington, T., The first dose of a Haemophilus influenzae type b conjugate vaccine reactivates memory B cells: evidence for extensive clonal selection, intraclonal affinity maturation, and multiple isotype switches to IgA2. J. Immunol. 1999. 162: 224-237.
43. Sanger, F., Nicklen, S. and Coulson, A. R., DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 1977. 74: 5463-5467.
44. Zhang, J. G., Moritz, R. L., Raid, G. E., Ward, L. D. and Simpson, R. J., Purification and characterization of a recombinant murine interleukin-6. Isolation of N- and C-terminally truncated forms. Eur. J. Biochem. 1992. 207: 903-913.
45. Hansen, M. B., Nielsen, S. E. and Berg, K., Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 1989. 119: 203-210.